Cargando…
Performance characteristics between TDx®FLx and TBA™-25FR for the therapeutic drug monitoring of methotrexate
BACKGROUND: High-dose methotrexate (HDMTX) is used in the treatment of certain malignancies, including leptomeningeal metastases, systemic non-Hodgkin lymphoma, acute lymphoblastic leukemia, and osteosarcoma. High circulating levels of methotrexate can cause severe myelosuppression. The present stud...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782285/ https://www.ncbi.nlm.nih.gov/pubmed/26958349 http://dx.doi.org/10.1186/s40780-016-0042-y |